Skip to main content
. 2016 Dec 22;12:115–122. doi: 10.2147/COPD.S114802

Table 2.

Baseline patient characteristics: overall and by mCOPD medication adherence statusa

Baseline patient characteristic Overall
(n=14,117)
Adherent to mCOPD medications
(n=2,940)
Non-adherent to mCOPD medications
(n=11,177)
P-value
Age, years
Mean (SD) 69.9 (±9.2) 69.8 (±8.8) 70.0 (±9.3) 0.3402
Median (IQR) 70.0 (66.0–76.0) 70.0 (66.0–76.0) 70.0 (66.0–76.0)
Age category, n (%)
40–49 years 369 (2.6) 67 (2.3) 302 (2.7) 0.2008
50–59 years 1,471 (10.4) 305 (10.4) 1,166 (10.4) 0.9270
60–69 years 4,799 (34.0) 1,022 (34.8) 3,777 (33.8) 0.3235
70–79 years 5,324 (37.7) 1,135 (38.6) 4,189 (37.5) 0.2620
80–89 years 2,154 (15.3) 411 (14.0) 1,743 (15.6) 0.0303
Sex, n (%)
Female 8,348 (59.1) 1,769 (60.2) 6,579 (58.9) 0.1992
Male 5,769 (40.9) 1,171 (39.8) 4,598 (41.1)
Geographic location, n (%)
Northeast 254 (1.8) 76 (2.6) 178 (1.6) 0.0003
Midwest 3,481 (24.7) 858 (29.2) 2,623 (23.5) <0.0001
South 9,285 (65.8) 1,740 (59.2) 7,545 (67.5) <0.0001
West 1,097 (7.8) 266 (9.0) 831 (7.4) 0.0037
Line of business, n (%)
Medicare 13,512 (95.7) 2,789 (94.9) 10,723 (95.9) 0.0105
Commercial 605 (4.3) 151 (5.1) 454 (4.1)
RxRisk-V comorbidity scoreb
Mean (SD) 7.2 (±3.1) 7.0 (±3.1) 7.2 (±3.1) 0.0004
Median (IQR) 7.0 (5.0–9.0) 7.0 (5.0–9.0) 7.0 (5.0–9.0)
Influenza vaccination status, n (%)
Nullc 5,488 (38.9) 1,042 (35.4) 4,446 (39.8) <0.0001
Partialc 4,434 (31.4) 957 (32.6) 3,477 (31.1) 0.1338
Fullc 4,195 (29.7) 941 (32.0) 3,254 (29.1) 0.0023

Notes:

a

Measured during the 12-month pre-index period.

b

RxRisk-V score without DME ranges from 0 to 42, with a higher score indicating a greater chronic disease burden.

c

Influenza vaccination status was based on the number and timing of vaccine claims during the post-index period as follows: null =0; partial = ≥1; full = ≥2 claims occurring 6 months or greater apart.

Abbreviations: DME, durable medical equipment; IQR, interquartile range; SD, standard deviation; mCOPD, maintenance COPD.